Oslo, 14 April 2020: In connection with the Annual General Meeting of Ultimovacs ASA to be held on 23 April 2020, Jónas Einarsson, Chairman of the Board of Directors, has so far received proxy based voting rights without voting instructions for 8,169,626 shares, representing 29.32% of the total voting rights in the company.
With the addition of the 1,395,875 shares controlled by Radforsk, Jónas Einarsson thus represents a total of 9,565,501 shares. This corresponds to 34.33% of the company’s total number of shares and votes in connection with the company’s ordinary Annual General Meeting.
The proxies are only valid for the Annual General Meeting on 23 April 2020.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please see www.ultimovacs.com or contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA je@radforsk.no, +47 480 96 355
Øyvind Kongstun Arnesen, CEO oeyvind.arnesen@ultimovacs.com, +47 469 33 810
Hans Vassgård Eid, CFO hans.eid@ultimovacs.com, +47 469 19 822